Additionally, coordinated autocrine expression of IL-6 and IL-8 stimulated the growth of TNBCs through NF-κB activation, conferred resistance to apoptosis and chemotherapy, and activated tumor growth [94]. The gene discussed is NFKB1; the disease is neoplasm.